Azora Therapeutics, Inc. (DE) (AZR)

Form 4 sales, Form 144 notices and lockup dates

Sales chart range
Log in to watch AZR
Latest sale
200,000
Oct 4 · Unusual
Form 4 sales
4
On record
Form 144 notices
0
Proposed sales
Next unlock
None
No lockup ahead

Lockups

No lockup on record.

Sales by reason

0
Routine
2
Plan not stated
0
No plan
2
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Timeline

  1. Oct 4, 2021Unusual

    Johnson Bankole A., Chief Medical Officer, sold 57.4% of their holdings

    200,000 shares

    Filed Oct 6, 2021Form 4

  2. Apr 6, 2021Plan not stated

    Johnson Bankole A., Chief Medical Officer, sold 21.5% of their holdings

    $375k150,000 shares at $2.50

    Filed Apr 8, 2021Form 4

  3. Aug 20, 2020Unusual

    Johnson Bankole A., Chief Medical Officer, sold 99.7% of their holdings

    $424k350,000 shares at $1.21

    Filed Aug 24, 2020Form 4

  4. Dec 12, 2019Plan not stated

    Johnson Bankole A., Chief Medical Officer, sold 17.7% of their holdings

    $150k150,000 shares at $1.00

    Filed Dec 13, 2019Form 4

4 of 4

Every transaction

Every transaction on a Form 4 or Form 5 for AZR
TradedFiledStockNameRoleWhatAmountPriceValueHeld afterSource
Nov 2, 2026Nov 4, 2026AZRDavidson MattPresident and CEOConvertedSeries A Preferred Stock6260SEC
Nov 2, 2026Nov 4, 2026AZRDavidson MattPresident and CEOConverted626,252104,725SEC
Oct 28, 2026Oct 30, 2026AZRDavidson MattPresident and CEOAwardedSeries A Preferred Stock886,128333,830SEC
Oct 28, 2026Oct 30, 2026AZRDavidson MattPresident and CEOAwarded232,417294,064SEC
Sep 17, 2026Sep 21, 2026AZRYoung Wendy B.DirectorAwardedStock Option (Right to Buy)25,66625,666SEC
Jul 16, 2026Jul 16, 2026AZRCoastlands Capital LP10% ownerBought3,233$2.69$9k388,308SEC
Jul 10, 2026Jul 13, 2026AZRCoastlands Capital LP10% ownerBought11,753$2.78$33k385,075SEC
Jun 29, 2026Jul 1, 2026AZRCoastlands Capital LP10% ownerBought25,000$2.60$65k373,322SEC
Jun 12, 2026Jun 16, 2026AZRDavidson MattChief Development OfficerAwardedStock Option (Right to Buy)232,417232,417SEC
Jun 12, 2026Jun 16, 2026AZRDavidson MattChief Development OfficerAwarded299,4141,923SEC
Jun 12, 2026Jun 16, 2026AZRYoung Wendy B.DirectorBoughtPre-funded Warrant36,378$2.75$100k36,378SEC
Apr 7, 2026Apr 9, 2026AZRAnderson J. KermitDirectorAwardedStock Option (Right to Buy)9,1859,185SEC
Apr 7, 2026Apr 9, 2026AZRGoodman TonyChief Operating OfficerAwarded26,51026,523SEC
Apr 7, 2026Apr 9, 2026AZRShah VinayChief Financial OfficerAwarded17,32517,325SEC
Apr 7, 2026Apr 9, 2026AZRSchuyler KevinDirectorAwarded9,1859,213SEC
Apr 7, 2026Apr 9, 2026AZRGilliland Robertson H.DirectorAwarded9,1859,185SEC
Apr 7, 2026Apr 9, 2026AZRClaiborne Cary JChief Executive OfficerAwarded37,98540,417SEC
May 29, 2025Jun 2, 2025AZRGilliland Robertson H.DirectorAwardedStock Option (Right to Buy)28,00028,000SEC
May 29, 2025Jun 2, 2025AZRNewman James W. Jr.DirectorAwardedStock Option (Right to Buy)28,00028,000SEC
May 29, 2025Jun 2, 2025AZRShah VinayChief Financial OfficerAwardedStock Option (Right to Buy)9,0009,000SEC
May 29, 2025Jun 2, 2025AZRSchuyler KevinDirectorAwardedStock Option (Right to Buy)28,00028,000SEC
May 29, 2025Jun 2, 2025AZRClaiborne Cary JChief Executive OfficerAwardedStock Option (Right to Buy)138,000138,000SEC
May 29, 2025Jun 2, 2025AZRGoodman TonyChief Operating OfficerAwardedStock Option (Right to Buy)94,00094,000SEC
May 29, 2025Jun 2, 2025AZRAnderson J. KermitDirectorAwardedStock Option (Right to Buy)28,00028,000SEC
Dec 5, 2024Dec 5, 2024AZRClaiborne Cary JChief Executive OfficerAwardedStock Option (Right to Buy)350,000350,000SEC
Nov 16, 2024Nov 18, 2024AZRShah VinayChief Financial OfficerAwardedStock Option40,00040,000SEC
Mar 25, 2024Mar 27, 2024AZRGilliland Robertson H.DirectorAwardedStock Option (Right to Buy)12,00012,000SEC
Mar 25, 2024Mar 27, 2024AZRNewman James W. Jr.DirectorAwardedStock Option (Right to Buy)12,00012,000SEC
Mar 25, 2024Mar 27, 2024AZRTruluck JosephChief Financial OfficerAwardedStock Option (Right to Buy)25,00025,000SEC
Mar 25, 2024Mar 27, 2024AZRClaiborne Cary JChief Executive OfficerAwardedStock Option (Right to Buy)60,00060,000SEC
Mar 25, 2024Mar 27, 2024AZRAnderson J. KermitDirectorAwardedStock Option (Right to Buy)12,00012,000SEC
Mar 25, 2024Mar 27, 2024AZRSchuyler KevinDirectorAwardedStock Option (Right to Buy)12,00012,000SEC
Mar 25, 2024Mar 27, 2024AZRGoodman TonyChief Operating OfficerAwardedStock Option (Right to Buy)42,00042,000SEC
Sep 29, 2023Oct 3, 2023AZRSchuyler KevinDirectorBought700$2.74$2k700SEC
May 23, 2023Jun 2, 2023AZRJohnson Bankole A.DirectorAwardedStock Option40,00040,000SEC
May 23, 2023May 25, 2023AZRTruluck JosephChief Financial OfficerAwardedStock Option (Right to Buy)125,000125,000SEC
May 23, 2023May 25, 2023AZRTruluck JosephChief Financial OfficerAwarded157,500265,139SEC
May 23, 2023May 25, 2023AZRStilley William B. IIIDirectorAwardedStock Option (Right to Buy)50,00050,000SEC
May 23, 2023May 25, 2023AZRStilley William B. IIIDirectorAwarded240,8001.3MSEC
May 23, 2023May 25, 2023AZRSchuyler KevinDirectorAwardedStock Option (Right to Buy)50,00050,000SEC
May 23, 2023May 25, 2023AZRNewman James W. Jr.DirectorAwardedStock Option (Right to Buy)50,00050,000SEC
May 23, 2023May 25, 2023AZRGoodman TonyDirectorAwardedStock Option (Right to Buy)50,00050,000SEC
May 23, 2023May 25, 2023AZRGilliland Robertson H.DirectorAwardedStock Option (Right to Buy)50,00050,000SEC
May 23, 2023May 25, 2023AZRClaiborne Cary JChief Executive OfficerAwardedStock Option (Right to Buy)300,000300,000SEC
May 23, 2023May 25, 2023AZRClaiborne Cary JChief Executive OfficerAwarded420,0001.5MSEC
May 23, 2023May 25, 2023AZRAnderson J. KermitDirectorAwardedStock Option (Right to Buy)50,00050,000SEC
Dec 30, 2022Jan 3, 2023AZRStilley William B. IIIDirectorReturned to the company166,6671MSEC
Sep 20, 2022Sep 20, 2022AZRClaiborne Cary JChief Executive OfficerAwarded100,000$0.42$42k1.1MSEC
Aug 22, 2022Aug 23, 2022AZRStilley William B. IIIDirectorAwardedStock Options100,000100,000SEC
Aug 18, 2022Aug 22, 2022AZRClaiborne Cary JChief Executive OfficerAwarded1M1MSEC
Page 1

Sales, notices and lockups (4)

Export watchlist as CSV
Lockups, Form 144 notices and Form 4 sales for AZR
Source
Oct 4, 2021Oct 6, 2021Johnson Bankole A.AZRChief Medical OfficerForm 4 sale200,00057.4%UnusualSEC
Apr 6, 2021Apr 8, 2021Johnson Bankole A.AZRChief Medical OfficerForm 4 sale150,000$375k21.5%Plan not statedSEC
Aug 20, 2020Aug 24, 2020Johnson Bankole A.AZRChief Medical OfficerForm 4 sale350,000$424k99.7%UnusualSEC
Dec 12, 2019Dec 13, 2019Johnson Bankole A.AZRChief Medical OfficerForm 4 sale150,000$150k17.7%Plan not statedSEC